Trial Profile
A Trial of cetuximab for Treatment of metastatic colorectal cancer in outpatients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 03 Dec 2015 New trial record